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Requirement for CARMA1 in Antigen Receptor-Induced
NF-B Activation and Lymphocyte Proliferation
ways that result in the activation of NF-B converge on
the phosphorylation and activation of the IB kinase
(IKK) signalosome. IKK activation results in phosphory-
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Margot Thome,3 and Dan R. Littman1,2,* lation and subsequent ubiquitination and proteasomal
degradation of IB and thus frees up NF-B complexes1 Molecular Pathogenesis Program
2 Howard Hughes Medical Institute and permits their translocation to the nucleus [11]. It is
not understood, however, how the proximal lymphocyteSkirball Institute for Biomolecular Medicine
New York University School of Medicine antigen receptor-signaling machinery, including PKC,
is linked to IKK activation. Potential clues come from540 First Avenue
New York, New York 10016 studies of the trimolecular complexes formed by interac-
tions of CARD-containing MAGUKs, such as CARMA1-3,3 Institute of Biochemistry
University of Lausanne with Bcl10, which, in turn, binds to MALT1, a death-
domain-containing adaptor protein with homology toBiomedical Research Center
Chemin des Boveresses 155CH-1066 Epalinges caspases [12, 13]. Overexpression of each of these pro-
teins results in the activation of NF-B [3, 6]. JurkatSwitzerland
cells with mutant CARMA1 alleles, with siRNA-induced
reduction of CARMA1 expression, and with overex-
pressed CARD domain mutant CARMA1 displayed re-Summary
duced antigen receptor-mediated activation of NF-B
but normal TNFR- or IL-1R-induced NF-B activationLigation of antigen receptors (TCR, BCR) on T and B
[5–7]. Thus, CARMA1, like PKC and Bcl10, functions inlymphocytes leads to the activation of new transcrip-
a signaling pathway that is selectively engaged by thetional programs and cell cycle progression. Antigen
antigen receptor.receptor-mediated activation of NF-B, required for
To study the function of CARMA1 in mouse lympho-proliferation of B and T cells, is disrupted in T cells
cyte activation and development, we targeted the genelacking PKC and in B and T cells lacking Bcl10, a
by homologous recombination in ES cells and generatedcaspase recruitment domain (CARD)-containing adap-
mice with a LoxP-flanked neor gene inserted betweentor protein [1, 2]. CARMA1 (also called CARD11 and
exons 4 and 5 (Figures 1A and 1B). Immunoblot analysisBimp3), the only lymphocyte-specific member in a
indicated that CARMA1 expression was abolished infamily of membrane-associated guanylate kinase
splenocytes and thymocytes (Figure 1C and data not(MAGUK) scaffolding proteins that interact with Bcl10
shown). Mice with mutant alleles were born at normalby way of CARD-CARD interactions [3, 4], is required
Mendelian ratios and displayed no obvious abnormali-for TCR-induced NF-B activation in Jurkat T lym-
ties. Analysis of the thymus revealed normal cell num-phoma cells [5–7]. Here we show that T cells from
bers and normal thymocyte subset development as de-mice lacking CARMA1 expression were defective in
termined by CD4 and CD8 expression (Figure 2A). T cellrecruitment of Bcl10 to clustered TCR complexes and
numbers and ratios in lymph nodes were also normallipid rafts, in activation of NF-B, and in induction of
in mutant mice (Figure S1 in the Supplemental DataIL-2 production. Development of CD5 peritoneal B
available with this article online). However, further exam-cells was disrupted in these mice, as was B cell prolif-
ination of subsets within the thymocyte double-negativeeration in response to both BCR and CD40 ligation.
compartment (CD4CD8) via staining with anti-CD25Serum immunoglobulin levels were also markedly re-
and anti-CD44 antibodies showed a significant reduc-duced in the mutant mice. Together, these results
tion in the proportion of DN3 cells (CD25CD44lo) andshow that CARMA1 has a central role in antigen recep-
an increase in DN4 cells (CD25CD44lo) (Figures 2A, 2Btor signaling that results in activation and proliferation
and supplemental Figure S2). This appears to be dueof both B and T lymphocytes.
to premature maturation of the DN thymocytes, which
display precocious expression of surface TCR (Figure
Results and Discussion 2B). These DN cells also undergo an unusually high rate
of apoptosis, as revealed by Annexin V staining (Figure
Antigen receptor stimulation in B and T lymphocytes 2B). This thymic phenotype is very similar to that de-
results in rapid activation of membrane-proximal tyro- scribed in Bcl10-deficient mice [1]. It may be due to
sine kinases of the Src and Syk families, phosphorylation incomplete NF-B activation after selection of thymo-
of adaptor proteins, and binding of various cytosolic cytes that have rearranged their TCR genes and that
proteins to the newly phosphorylated adaptors [8]. In have been proposed to become dependent on NF-B
T cells, these events are required for recruitment of PKC activation for their survival and proliferation [14].
to the immunological synapse (IS) and for subsequent B lymphocyte development in bone marrow from
activation of NF-B [9]. In B cells, PKC is thought to CARMA1-deficient mice was normal (Figure S3). How-
serve a similar role [10]. Many different signaling path- ever, the population of CD5B220 B1 cells in perito-
neum was almost completely absent in the mutant mice
(Figure 2C). There was also a marked reduction in basal*Correspondence: littman@saturn.med.nyu.edu
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Figure 1. Targeted Disruption of the carma1 Locus
(A) The wild-type carma1 locus and the targeting vector (middle) are shown with EcoRI restriction enzyme sites (RI). The targeting vector was
designed to knock-in the loxP-flanked neomycin-resistant cassette (neor) into intron 4 and another loxP site into intron 2. The loxP sites and
exons are indicated with triangles and open rectangles, respectively. Real-time PCR analysis with cDNA from thymus and spleen showed
that expression levels of 3 adjacent genes Lfng and Gna12 and a 5 adjacent gene, Foxk1, were not affected by insertion of the neomycin
resistance cassette (data not shown). These loci are 260 kbp, 44 kbp, and 1.5 Mbp away from the carma1 gene, respectively, and all of these
genes are expressed in thymus and spleen.
(B) Southern blot analysis of genomic DNA from carma1 /, /FN, and FN/FN mice. Genomic DNA was digested with EcoRI and probed
with the 3 external probe shown as a shaded box in (A).
(C) Western blot analysis for CARMA1 and Bcl10 expression in splenocytes from carma1 / and FN/FN mice. A monoclonal antibody specific
for residues 804–959 (a kind gift from V. Dixit, Genentech) was used.
serum immunoglobulin levels, particularly levels of IgM, (Figure 3A). Proliferation in response to anti-CD3/anti-
CD28 was also significantly impaired in T cells from theIgG1, IgG2b, IgG3, and IgA isotypes (Figure 2D). A similar
reduction in basal immunoglobulins was reported in carma1FN/FN mice (Figure 3B). This defect was chiefly due
to the reduced production of IL-2 (Figure 3C); prolifera-Bcl10-deficient mice [1]. Selective loss of B1 cells
accompanied by reduced immunoglobulin levels has tion in response to anti-CD3 was restored when IL-2
was added back (Figure 3B). There was no differencealso been described in mice deficient for proximal B cell
signaling components required for induction of NF-B and in IL-2 production when CARMA1-deficient and wild-type
cells were activated with PMA plus ionomycin, althoughproliferative responses, including Btk and PKC [15].
We next compared responses of mature T cells from there was a blunting of the proliferative response, proba-
bly due to the poor upregulation of CD25, a componentmutant mice and wild-type littermates to various stimuli.
There was reduced upregulation of cell-surface CD25 of the high-affinity IL-2 receptor (Figures 3A–3C). Very
similar results were observed with T cells from pkc/and CD69 in cells from carma1FN/FN mice compared to
control mice after stimulation with anti-CD3 or anti-CD3 mice, consistent with our previous findings [2].
B cells from CARMA1-deficient mice also exhibitedplus anti-CD28 (Figure 3A). This defect was considerably
more severe in cells from mutant mice after stimulation defects in activation. Proliferation in response to anti-
IgM, which stimulates the BCR, to anti-CD40, or to awith the phorbol ester PMA with or without ionomycin
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Figure 2. Analysis of B and T Cell Subsets and Serum Immunoglobulin Levels in carma1FN/FN Mice
(A) Flow-cytometric analysis of CD4 and CD8 expression on thymocytes (top) and CD25 and CD44 expression in the Lin
(CD4CD8B220TCR	Gr1Mac1) thymocyte subpopulation (bottom). Percentages of cells within each quadrant are indicated.
(B) TCR and TCR expression and AnnexinV staining in Lin thymocytes.
(C) CD5 and B220 expression in Mac1lo/-gated peritoneal cells.
Results in (A)–(C) are representative data from four different experiments.
(D) Decreased baseline serum immunoglobulin levels in carma1FN/FN mice. Concentration of serum immunoglobulin of each isotype was
determined by ELISA in serum samples from 6- to 8-week-old carma1FN/FN mice (M, shaded circles, n 
 4), and littermate wild-type mice (W,
open circles, n 
 4). Mean values are shown by horizontal bars.
combination of the two was markedly reduced (Figure very similar to those previously observed in Bcl10-defi-
cient mice [1].3D). However, the Tlr4 signaling pathway induced by
LPS was intact in the mutant B cells. These results are To determine whether CARMA1 is required for NF-B
wild-type mice (open bars), carma1FN/FN mice (filled bars), and pkc/ mice (hatched bars) and stimulated for 72 hr with 5 g/ml of plate bound
anti-CD3 alone or with 5 g/ml of anti-CD28 or 10 U/ml of recombinant IL-2. Alternatively, cells were stimulated with 100 ng/ml of PMA with
or without 200 ng/ml of ionomycin. Proliferative responses were measured by 3H thymidine incorporation in (B). For measurement of IL-2
production (C), culture supernatants were harvested 30 hr after stimulation, and IL-2 levels were determined by examination of proliferation
of the IL-2 dependent cell line CTLL-2 for 48 hr. Representative results from four independent experiments are shown as mean values and
standard deviations.
(D) Defective B cell proliferation induced by BCR and CD40 crosslinking in the absence of CARMA1. Purified B cells were stimulated for 48
hr with anti-IgM (10 g/ml) antibodies, anti-CD40 (10 g/ml) antibodies, anti-IgM  anti-CD40 antibodies, anti-IgM antibody  IL-4 (5 U/ml),
or LPS (1 g/ml), and proliferation was measured by 3H thymidine incorporation.
(E) TCR-induced NF-B activation in CARMA1-deficient thymocytes and CD4 T cells. Thymocytes and purified CD4 T cells were stimulated
for 8 hr with 10 g/ml of plate bound anti-CD3 with or without 10 g/ml of anti-CD28 antibody or were stimulated with 100 ng/ml of PMA
with or without 200 ng/ml of ionomycin (Iono). NF-B activation was examined by electrophoretic mobility shift assay. Nuclear extract from
thymocytes and CD4 T cells treated with 20 g/ml of TNF was used as a control.
(F) Defective IB degradation induced by TCR stimulation in carma1FN/FN CD4 T cells. Purified CD4 T cells were stimulated with 10 g/ml
of anti-CD3 or 20 g/ml of TNF for different durations as indicated. Cytosolic extracts were subjected to Western blotting with antibodies
against IB. The same blots were probed with an anti-p56lck antibody for a loading control.
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Figure 3. Impaired Lymphocyte Activation in CARMA1-Deficient Mice
(A) Surface expression of CD25 and CD69 after activation of the TCR signaling pathway. CD4 T cells from mutant mice (open histogram)
or control littermates (filled histogram) were stained with anti-CD25 and anti-CD69 antibodies 16 hr after stimulation with 10 g/ml of plate
bound anti-CD3 with or without 10 g/ml of anti-CD28 antibody or after stimulation with 50 ng/ml of PMA with or without 200 ng/ml of
ionomycin and then analyzed by flow cytometry. Representative data from three independent experiments with similar results are shown.
(B and C) Impaired proliferation and IL-2 production of CD4 T cells in the absence of CARMA1 expression. CD4 T cells were purified from
(legend continues on previous page)
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Figure 4. Defective Bcl10 but Normal PKC Recruitment to Clustered TCR Complexes and Lipid Rafts in the Absence of CARMA1
(A) Purified CD4 T cells labeled with Alexa488-conjugated cholera toxin B subunit (CTX, green) were treated with anti-CTX antibody for 30
min at 37C and stained for Bcl10 (Cy5, red) after fixation.
(B and C) Purified CD4 T cells from wild-type, carma1FN/FN and pkc/ mice were incubated with latex beads coated with anti-CD3 and anti-
CD28 antibodies or BSA for 30 min at 37C and stained for (B) Bcl10 (FITC, green) and Carma1 (Cy5, blue) or (C) for PKC (Alexa488, green)
after fixation.
activation in mouse lymphocytes, we analyzed nuclear from mutant mice (Figure 3F). However, a reduction was
observed in cells from both sets of mice after treatmentextracts from thymocytes and CD4 T cells in electro-
phoretic mobility shift assays. NF-B activation follow- with TNF. Together, these results indicate that NF-B
activation following TCR ligation is compromised in miceing stimulation with anti-CD3/CD28 and PMA with or
without ionomycin was only slightly reduced in thymo- lacking CARMA1 and confirm that this pathway for IKK
activation is distinct from that downstream of the TNFcytes from mutant and wild-type mice (Figure 3E). In
contrast, there was a marked reduction in NF-B activa- receptor. These results are consistent with phenotypes
reported for T cells from mice lacking c-Rel or both c-Reltion in CARMA1-deficient mature T cells after TCR stim-
ulation or phorbol treatment. However, NF-B activation and p50, which had no NF-B activation and IL-2 pro-
duction after TCR stimulation [16, 17].in response to TNF treatment was intact in these cells.
Monitoring the level of IB after various stimuli can The similarity of the B and T cell phenotypes observed
in the absence of CARMA1 and Bcl10 supports the no-also serve as a gauge for activation of the IKK signaling
pathway. After anti-CD3 treatment, IB was reduced tion that these molecules are closely associated in a
signaling complex involved in the activation of NF-B.in wild-type T cells but remained unchanged in T cells
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